FTC order in TruHeight case signals scrutiny of height claims and incentivized reviews
Regulators, legal experts and company executives weigh in as the FTC’s TruHeight case signals increased scrutiny of clinical claims and incentivized reviews in supplements.
Read the full article on the original site.
Read Full Article